Lidocan Vii Patch
Product Images NDC 59088-900

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lidocan Vii (NDC 59088-900). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Puretek Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Drug (Drug Asso)

This is a list of drug classes and examples within each class such as Nitrates/Nitrites including nitric oxide and nitroglycerin, local anesthetics like lidocaine and benzocaine, antineoplastic agents like hydroxyurea, and antibiotics including sulfonamides. The list also includes antimalarials, anticonvulsants, and other drugs like acetaminophen and metoclopramide.*

FDA Label Image

Label (Label Lidocan Vii)

This is a product label for a Lidocaine Patch 5% called "DERMACINR" prescribed for topical anesthesia and anti-inflammatory purposes. Each patch contains 700g of Lidocaine and other inactive ingredients. The usual dosage is up to 3 patches, and it is for external use only. The label includes storage instructions and a warning to keep patches out of reach of children and pets. Each patch is 10cm x 14cm in size.*

FDA Label Image

Graphs (Graphs)

This is a graph showing the plasma concentration of Lidocaine in ng/mL over a period of 72 hours. The concentration starts at around 120 ng/mL and gradually decreases over time. The graph includes data points at specific time intervals (12, 18, 24, 30, 36, 42, 48, 54, 60, 66, 72 hours).*

FDA Label Image

Molecule (Molecule)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.